These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11786277)

  • 21. A novel tetrabranched neurotensin(8-13) cyclam derivative: synthesis, 64Cu-labeling and biological evaluation.
    Röhrich A; Bergmann R; Kretzschmann A; Noll S; Steinbach J; Pietzsch J; Stephan H
    J Inorg Biochem; 2011 Jun; 105(6):821-32. PubMed ID: 21497581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescein-labeled stable neurotensin derivatives.
    Maes V; Hultsch C; Kohl S; Bergmann R; Hanke T; Tourwé D
    J Pept Sci; 2006 Aug; 12(8):505-8. PubMed ID: 16671056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toward stable N4-modified neurotensins for NTS1-receptor-targeted tumor imaging with 99mTc.
    Nock BA; Nikolopoulou A; Reubi JC; Maes V; Conrath P; Tourwé D; Maina T
    J Med Chem; 2006 Jul; 49(15):4767-76. PubMed ID: 16854083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Syntheses, receptor bindings, in vitro and in vivo stabilities and biodistributions of DOTA-neurotensin(8-13) derivatives containing β-amino acid residues - a lesson about the importance of animal experiments.
    Sparr C; Purkayastha N; Yoshinari T; Seebach D; Maschauer S; Prante O; Hübner H; Gmeiner P; Kolesinska B; Cescato R; Waser B; Reubi JC
    Chem Biodivers; 2013 Dec; 10(12):2101-21. PubMed ID: 24327436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging Neurotensin Receptor in Prostate Cancer With
    Deng H; Wang H; Zhang H; Wang M; Giglio B; Ma X; Jiang G; Yuan H; Wu Z; Li Z
    Mol Imaging; 2017; 16():1536012117711369. PubMed ID: 28849698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiolabeled ligands specific for the G protein-coupled state of neurotensin receptors.
    Gaudriault G; Zsürger N; Vincent JP
    J Neurochem; 1996 Dec; 67(6):2590-8. PubMed ID: 8931494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catabolism of neurotensins. Implications for the design of radiolabeling strategies of peptides.
    Schubiger PA; Allemann-Tannahill L; Egli A; Schibli R; Alberto R; Carrel-Rémy N; Willmann M; Bläuenstein P; Tourwé D
    Q J Nucl Med; 1999 Jun; 43(2):155-8. PubMed ID: 10429510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [99mTc]Demotensin 5 and 6 in the NTS1-R-targeted imaging of tumours: synthesis and preclinical results.
    Maina T; Nikolopoulou A; Stathopoulou E; Galanis AS; Cordopatis P; Nock BA
    Eur J Nucl Med Mol Imaging; 2007 Nov; 34(11):1804-14. PubMed ID: 17594090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and structure-activity relationships of C-terminal cyclic neurotensin fragment analogues.
    Sefler AM; He JX; Sawyer TK; Holub KE; Omecinsky DO; Reily MD; Thanabal V; Akunne HC; Cody WL
    J Med Chem; 1995 Jan; 38(2):249-57. PubMed ID: 7830267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of
    Marenco M; Lodola L; Persico MG; Frangipane V; Facoetti A; Aprile C; Hodolič M
    Curr Pharm Biotechnol; 2018; 19(9):754-759. PubMed ID: 30160211
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of [
    Wang M; Zhang H; Wang H; Feng H; Deng H; Wu Z; Lu H; Li Z
    Mol Pharm; 2018 Aug; 15(8):3093-3100. PubMed ID: 29889537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1,2,3-Triazole Stabilized Neurotensin-Based Radiopeptidomimetics for Improved Tumor Targeting.
    Mascarin A; Valverde IE; Vomstein S; Mindt TL
    Bioconjug Chem; 2015 Oct; 26(10):2143-52. PubMed ID: 26347939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog.
    Cheng Z; Zhang L; Graves E; Xiong Z; Dandekar M; Chen X; Gambhir SS
    J Nucl Med; 2007 Jun; 48(6):987-94. PubMed ID: 17504880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of novel multimeric neurotensin(8-13) analogs.
    Hultsch C; Pawelke B; Bergmann R; Wuest F
    Bioorg Med Chem; 2006 Sep; 14(17):5913-20. PubMed ID: 16735124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro analysis of stable, receptor-selective neurotensin[8-13] analogues.
    Kokko KP; Hadden MK; Orwig KS; Mazella J; Dix TA
    J Med Chem; 2003 Sep; 46(19):4141-8. PubMed ID: 12954066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurotensin receptors: binding properties, transduction pathways, and structure.
    Vincent JP
    Cell Mol Neurobiol; 1995 Oct; 15(5):501-12. PubMed ID: 8719037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor affinity of neurotensin message segment immobilized on liposome.
    Zhao J; Kimura S; Imanishi Y
    Biochim Biophys Acta; 1996 Jul; 1282(2):249-56. PubMed ID: 8703980
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activation of neurotensin receptors and purinoceptors in human colonic adenocarcinoma cells detected with the microphysiometer.
    Richards M; van Giersbergen P; Zimmermann A; Lesur B; Hoflack J
    Biochem Pharmacol; 1997 Oct; 54(7):825-32. PubMed ID: 9353137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
    Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
    Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of N-terminal modifications on neurotensin(8-13) analogues correlates peptide stability but not binding affinity with in vivo efficacy.
    Orwig KS; Lassetter MR; Hadden MK; Dix TA
    J Med Chem; 2009 Apr; 52(7):1803-13. PubMed ID: 19290594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.